Mixed options sentiment in Moderna (MRNA), with shares down 50c near $26.36. Options volume relatively light with 22k contracts traded and puts leading calls for a put/call ratio of 1.07, compared to a typical level near 0.91. Implied volatility (IV30) dropped 3.25 near 82.52,in the top quartile of the past year, suggesting an expected daily move of $1.37. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: Moderna (MRNA) will report earnings before the open on 2025-11-06.Option markets are pricing in a 50% probability of a move greater than 11.33% or $2.99.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- VOO ETF News, 10/23/2025
- Optimistic Outlook on Moderna’s Oncology Pipeline Amid CMV Setbacks: Buy Rating Reiterated
- Moderna’s Financial Challenges: Declining Vaccine Sales and High Cash Burn Rate Lead to Sell Rating
- Moderna’s Hold Rating: Impact of CMVictory Study and Vaccine Program Risks
- Moderna price target lowered to $40 from $70 at UBS